Published in
Wiley Open Access, Cancer Medicine, S1(11), p. 40-46, 2022
DOI: 10.1002/cam4.5108
Links
Tools
Use of multikinase inhibitors/lenvatinib concomitant with locoregional therapies for the treatment of radioiodine‐refractory differentiated thyroid cancer
Journal article published in 2022 by
Miguel‐Ángel Berciano‐Guerrero 
This paper is made freely available by the publisher.
Full text: Download
Data provided by 